Here we used an established model of type-1 diabetes (T1DM) where streptozocin (STZ) induces cell death of β-pancreatic cells, leading to decreased insulin production, thus promoting elevated blood glucose levels [26]. Here, INS is linked to type 1 diabetes mellitus.